Ondansetron is one of those “easy points” drugs on Step 1—until the question writer starts layering in chemo, postoperative nausea, vagal afferents, QT prolongation, and a distractor about motion sickness. This post will lock in what ondansetron is, exactly where it works, when you use it, and the classic high-yield associations you’re expected to recognize instantly.
Big Picture: What Ondansetron Is
Ondansetron is a selective 5-HT (serotonin) receptor antagonist used to treat nausea and vomiting, especially:
- Chemotherapy-induced nausea and vomiting (CINV)
- Postoperative nausea and vomiting
- Often used in the ED/hospital for general antiemesis (e.g., gastroenteritis)—though boards emphasize the classic indications above.
First Aid Cross-Reference (where it lives)
In First Aid Step 1, ondansetron is typically found under:
- GI Pharmacology → Antiemetics
- Alongside: metoclopramide, prochlorperazine, promethazine, scopolamine, aprepitant
(Exact page numbers vary by edition, but the section is consistent.)
Mechanism of Action (MOA): Where It Works and Why It Matters
The receptor: 5-HT
- 5-HT is a ligand-gated ion channel (not a GPCR)—high yield detail that Step 1 loves.
- It’s involved in triggering the vomiting reflex via:
- Peripheral pathways: vagal afferents in the GI tract
- Central pathways: the chemoreceptor trigger zone (CTZ) in the area postrema
What triggers the nausea in chemo?
Chemotherapy (and radiation) causes enterochromaffin cells in the small intestine to release serotonin (5-HT) → serotonin activates 5-HT receptors on vagal afferents → signals the medullary vomiting center → emesis.
Ondansetron blocks this signal at:
- Vagal afferent terminals in the GI tract
- CTZ (area postrema)
Boards translation: If the stem screams “chemo” or “post-op” and the answer choices include a 5-HT antagonist—pick it unless QT issues are the twist.
Pathophysiology of Nausea/Vomiting (Step-Friendly Map)
Different antiemetics map to different inputs into the vomiting center:
| Trigger/Setting | Key Pathway | Best-Class Drug | Why |
|---|---|---|---|
| Chemotherapy | 5-HT release from enterochromaffin cells → vagal afferents (5-HT) | Ondansetron | Blocks 5-HT peripherally + centrally |
| Post-op nausea | Multifactorial; serotonin plays a role | Ondansetron | Common prophylaxis/treatment |
| Motion sickness | Vestibular apparatus → H, M | Scopolamine, 1st-gen antihistamines | Ondansetron usually not best |
| Gastroparesis | Impaired motility | Metoclopramide | Prokinetic via D blockade |
| Migraine-associated nausea | Dopamine + other pathways | D antagonists, 5-HT agents sometimes | Depends on vignette |
Clinical Presentation: When You’ll See It in Vignettes
Classic Step 1 scenarios
- Patient receives cisplatin (or other highly emetogenic chemo) → severe nausea/vomiting → give ondansetron
- Postoperative patient (esp. after inhaled anesthetics/opioids) with nausea → ondansetron
- Hospitalized patient with vomiting where the question tests mechanism and adverse effects
What it’s not classically for
- Motion sickness: think scopolamine or meclizine/dimenhydrinate
- Morning sickness: doxylamine + pyridoxine is classic (Step-dependent nuance); ondansetron may appear clinically, but board questions usually test the classic first-line pair.
Diagnosis: Not of the Drug, But of the Nausea Pattern
Ondansetron is a treatment, so “diagnosis” on exams usually means recognizing:
- Chemo-related nausea/vomiting (timing after infusion, classic association)
- Postoperative nausea
- “Central vs peripheral” triggers (CTZ vs vestibular vs GI)
Common test move: The stem gives a nausea trigger (e.g., motion sickness), and ondansetron is an attractive distractor. If the vignette involves the vestibular system, 5-HT blockade won’t be the best choice.
Treatment: How It’s Used (Step-Relevant)
Indications you should memorize
- Chemotherapy-induced nausea/vomiting
- Postoperative nausea/vomiting
Practical pairings you may see
- In highly emetogenic chemo regimens, ondansetron may be combined with:
- Dexamethasone
- NK receptor antagonist (e.g., aprepitant)
You don’t need dosing for Step 1, but you do need the “combo therapy for severe CINV” concept.
Adverse Effects & Contraindications (HIGH-YIELD)
Must-know adverse effects
- QT prolongation → risk of torsades de pointes
- Especially relevant if the stem includes:
- congenital long QT
- electrolyte abnormalities (hypokalemia, hypomagnesemia)
- other QT-prolonging drugs (antiarrhythmics class IA/III, antipsychotics, macrolides, fluoroquinolones, etc.)
- Especially relevant if the stem includes:
- Headache
- Constipation
- Sometimes transient LFT elevations (less commonly tested)
High-yield warning: Serotonin syndrome?
Ondansetron is serotonergic adjacent (it blocks a serotonin receptor), and real-world debates exist, but Step-style questions overwhelmingly test QT prolongation, not ondansetron-induced serotonin syndrome. If serotonin syndrome is the goal, the vignette will usually feature:
- MAOIs, SSRIs/SNRIs, linezolid, tramadol, meperidine, triptans, dextromethorphan, St. John’s wort, etc.
Takeaway: For Step 1, anchor on QT prolongation.
HY Associations & “Buzzword → Drug” Connections
If you see this… think ondansetron
- Cisplatin (or “highly emetogenic chemotherapy”)
- Postoperative nausea prophylaxis
- “Blocks serotonin receptor that is a ligand-gated ion channel”
- “Acts at CTZ and vagal afferents”
Common “gotcha” comparisons
- Motion sickness → scopolamine / 1st-gen H blockers (not ondansetron)
- Gastroparesis/diabetic delayed gastric emptying → metoclopramide (prokinetic)
- Antipsychotic-like side effects / dystonia → dopamine antagonists (metoclopramide, prochlorperazine), not ondansetron
Rapid Comparison Table (Antiemetics You’ll Mix Up)
| Drug/Class | Receptor Target | Best Use | Classic Adverse Effect |
|---|---|---|---|
| Ondansetron | 5-HT antagonist | Chemo, post-op nausea | QT prolongation, headache, constipation |
| Metoclopramide | D antagonist (also ↑ ACh in gut) | Gastroparesis, reflux, antiemetic | EPS, hyperprolactinemia, tardive dyskinesia |
| Prochlorperazine / Promethazine | D antagonist / H antagonist (varies) | General nausea | Sedation, EPS (esp. D blockers) |
| Scopolamine | M antagonist | Motion sickness | Anticholinergic effects |
| Aprepitant | NK antagonist | Chemo nausea (combo regimens) | Fatigue, hiccups; CYP interactions |
Step 1 Style Mini-Vignettes (Practice Your Reflexes)
1) Chemo vignette
A patient receiving chemotherapy develops severe nausea and vomiting. A drug is given that blocks a ligand-gated ion channel in the GI tract and CTZ.
Answer: Ondansetron (5-HT)
2) QT twist
A post-op patient with nausea is about to receive ondansetron, but the ECG shows a markedly prolonged QT interval.
Tested concept: Ondansetron can prolong QT → torsades risk.
3) Motion sickness distractor
A patient becomes nauseated on a boat trip. Which drug is best for prevention?
Answer: Scopolamine or a 1st-gen H antihistamine (not ondansetron)
Final High-Yield Takeaways (Memorize These)
- Ondansetron = 5-HT antagonist (ligand-gated ion channel)
- Works peripherally (vagal afferents) and centrally (CTZ)
- Best for chemo-induced and postoperative nausea/vomiting
- Major adverse effect: QT prolongation (think torsades risk)
- Not the go-to for motion sickness (use scopolamine/H blockers)